Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 26, 2021

View Archived Issues

CT-859 improves survival in a murine NASH model

New animal model reveals effects of TM6SF2 gene variant on VLDL lipidation

Preclinical data presented for recombinant myxoma virus MC509-N1 in cancer

Adenosine A2A receptor antagonists identified at Adorx Therapeutics

New MAP4K1 inhibitors synthesized at Pfizer

Takeda Pharmaceutical presents new ABCC2 inhibitors

Merck, Cancer Research Technology divulge YAP1/TEAD interaction inhibitors

Sinocelltech patents Fc fragment fusion protein glycoconjugates

Study reports tumors change as patients age

Glycotope's tumor-targeting IL-15-based immunocytokine shows efficacy in preclinical models

Repurposing of riluzole for the treatment of Niemann-Pick disease, type C1

Attenuated measles vaccine expressing the S antigen protects mice and hamsters from SARS-CoV-2

SHP-1 abundance determines the responsiveness of an individual NK cell

Compounds targeting NPC1 protein show promising antiviral activity against SARS-CoV-2

Osteoclasts modified with tetracycline show efficacy in models of heterotopic ossification

ALD-2510 selectively depletes tumor-infiltrating Tregs for activity in vivo

Polycystic ovary syndrome murine model reveals CYP17 involvement

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...